Roundhill Glp-1 & Weight Loss ETF OZEM

Morningstar Medalist Rating

Morningstar’s Analysis OZEM

Will OZEM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Roundhill GLP-1 & Weight Loss ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OZEM

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings72.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

20.4712M
Healthcare

Novo Nordisk AS ADR

11.036M
Healthcare

Chugai Pharmaceutical Co Ltd

7.144M
Healthcare

Hanmi Pharm Co Ltd

6.804M
Healthcare

Pfizer Inc

5.783M
Healthcare

First American Government Obligs X

4.743M
Cash and Equivalents

Kailera Therapeutics Inc

4.703M
Healthcare

CSPC Pharmaceutical Group Ltd

4.673M
Healthcare

Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H

4.202M
Healthcare

Hansoh Pharmaceutical Group Co Ltd

3.782M
Healthcare

Sponsor Center